Riskpilot← Back to searchSign inGet full accessCarbin Urologi AB
ABDissolvedOrg 5565026779Artistic creation · NACE 9003Est. 19940 employees
Revenue 2020
SEK 502K
-73% vs 2019
EBITDA margin
75.7%
-26% vs 2019
Equity ratio
83.0%
Financial strength
Net profit 2020
SEK 262K
-60% vs 2019
| Revenue | SEK 502K | -73% |
| EBITDA | SEK 380K | -26% |
| Net profit | SEK 262K | -60% |
| Total assets | SEK 4,2M | -9% |
| Equity | SEK 3,5M | +8% |
| Employees | 0 | — |
Legal name
Carbin Urologi AB
Org number
5565026779
Legal form
Aktiebolag
NACE code
9003 · Artistic creation
Founded
13 december 1994
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-06-30
Financial year
January – December
Company purpose
Bolaget skall bedriva läkarverksamhet med medicinsk rådgivning med därtill hörande konsulttjänster, handel och förvaltning av fast egendom och värdepapper samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | 4 598 | 3 754 | 3 129 | 1 843 | 502 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 385 | 869 | 5 | 511 | 380 |
| Depreciation & amort. | −200 | −238 | −187 | −75 | −38 |
| EBIT | 1 185 | 631 | −182 | 436 | 342 |
| Net financials | −10 | 2 | −28 | −20 | — |
| Profit before tax | 1 239 | 723 | 571 | 870 | 342 |
| Tax | −320 | −169 | −142 | −208 | −80 |
| Net profit | 919 | 554 | 429 | 662 | 262 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Total assets | 6 700 | 6 283 | 5 226 | 4 595 | 4 199 |
| Equity | 3 581 | 3 135 | 2 564 | 3 225 | 3 487 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 795 | 1 913 | 2 209 | 1 370 | 712 |
| Total debt | 1 795 | 1 913 | 2 209 | 1 370 | 712 |
EBITDA margin
75.7%
This company
15.8%
Market median
+379% vs market
20162020
Equity ratio
83.0%
This company
38.2%
Market median
+117% vs market
20162020
Return on equity
7.5%
This company
18.4%
Market median
-59% vs market
20162020
Net profit margin
52.2%
This company
8.1%
Market median
+544% vs market
20162020
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
20162020
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20162020
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-07-01 – 2016-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BR | Audit | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Carbin Urologi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bengt Rickard Sterner | Audit | 0 companies |
| Bengt-Erik Engelbert Carbin | Board of Directors | 0 companies |
| Johan Tobias Carbin | Deputy Board Member | 0 companies |